Quanzhou Fengze Hongbei Garment Co., Ltd. – Trademark Portfolio

Entity Type: 99

Quanzhou Fengze Hongbei Garment Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include CHOHB, HOBAY, and CHIDAME. The owner is based in St.,Fengze,Quanzhou,.

Rm3507,Stair B,Bldg.8,Yuhuayuan,No.1158,

Binhai St.,Bincheng Community,Donghai

St.,Fengze,Quanzhou, 362000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HOBAY
HOBAY
Registered 2020
CHIDAME
CHIDAME
Registered 2020
CHOHB
CHOHB
Registered 2019

Trademark Classifications

Quanzhou Fengze Hongbei Garment Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (3 filings)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Quanzhou Fengze Hongbei Garment Co., Ltd. have?

Quanzhou Fengze Hongbei Garment Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Quanzhou Fengze Hongbei Garment Co., Ltd. file in?

Quanzhou Fengze Hongbei Garment Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Quanzhou Fengze Hongbei Garment Co., Ltd.'s most well-known trademarks?

Quanzhou Fengze Hongbei Garment Co., Ltd.'s registered trademark portfolio includes well-known marks such as CHOHB, HOBAY, and CHIDAME. These are among 3 currently registered trademarks in the portfolio.

What is Quanzhou Fengze Hongbei Garment Co., Ltd.'s trademark registration success rate?

Quanzhou Fengze Hongbei Garment Co., Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.